Personally, I’m no fan of marijuana. I don’t care if other people use it in the privacy of their own home, but it’s not for me. But here’s the inconvenient truth that my fellow conservatives need to hear about President Trump’s recent decision to reschedule marijuana: keeping cannabis classified alongside heroin as a Schedule I drug wasn’t protecting anyone. It was preventing us from gathering the very evidence we need to make informed decisions about public health and safety.
President Trump made the right decision to reschedule marijuana from Schedule I to Schedule III. This isn’t about going soft on drugs or embracing some liberal agenda. It’s about doing what conservatives have always championed: basing policy on facts, not feelings.
For decades, marijuana has sat in Schedule I, a category the federal government reserves for substances with “no accepted medical use.” Yet millions of Americans, including veterans suffering from PTSD and seniors managing chronic pain, use cannabis under their doctors’ supervision in states that have legalized medical marijuana. Leaving marijuana under the Schedule I classification created an absurd contradiction where the federal government was telling these patients and their physicians that they’re wrong about what helps them. That’s not what conservatives are about.
More troubling is what Schedule I status does to research. Federal restrictions make it extraordinarily difficult for scientists to study marijuana’s effects comprehensively. It prevents us from developing more accurate roadside impairment tests. We can’t definitively quantify the risks critics claim exist. We can’t establish proper dosing guidelines or quality standards. If marijuana truly is as dangerous as some claim, let’s prove it scientifically and then decide if more regulations are really needed.
This is where the argument for rescheduling becomes ironclad, even for skeptics like me. Moving cannabis to Schedule III doesn’t legalize recreational use. It doesn’t change state or local laws. What it does is remove bureaucratic barriers that prevent legitimate research. It allows the Food and Drug Administration to establish proper oversight. It enables law enforcement to develop better tools for detecting impairment. It brings cannabis under the same regulatory framework we use for countless prescription medications that also carry risks.
Consider what we’re up against. Critics point to concerns about addiction rates, potency increases, and traffic safety. These are legitimate issues that deserve serious attention. But the Schedule I classification prevents us from addressing them effectively. How can we educate the public about real dangers if we can’t conduct the research to identify them? How can we develop appropriate safeguards without proper scientific understanding?
Some Republicans worry that rescheduling sends the wrong message or represents surrender in the drug war. That’s backwards thinking. Real strength comes from facing problems head-on with the best available information, not burying our heads in the sand because the issue makes us uncomfortable. We don’t honor our veterans by denying them access to treatments that work, then blocking research into whether those treatments are safe. We don’t protect our kids by preventing scientists from studying how marijuana affects developing brains.
President Trump has built his political career on disrupting outdated establishment thinking. He’s shown willingness to challenge failed policies when the evidence demands it, and that’s exactly what he’s doing now. Rescheduling marijuana fits squarely within that approach. It’s not about personal preference or political correctness. It’s about acknowledging that our current system isn’t working and taking concrete steps to fix it.
This isn’t complicated. Rescheduling will give us the research we need to properly regulate marijuana. If dangers exist, we can establish those dangers in peer-reviewed studies, develop education programs based on solid data, and create enforcement tools that actually work.
Conversely, if there are legitimate medical benefits for certain patients, shouldn’t we be able to study those properly too? Shouldn’t doctors have access to reliable research when making treatment decisions? Shouldn’t veterans have the option to use therapies their physicians recommend without fear of federal consequences?
President Trump’s leadership on this issue transcends partisan politics. Rescheduling marijuana to Schedule III is the conservative position because it’s the evidence-based position. It protects patients, empowers researchers, strengthens public safety, and restores federal policy to alignment with scientific reality.
